NUVBNuvation Bio Inc - Ordinary Shares - Class A
NUVB
Nuvation Bio Inc - Ordinary Shares - Class A2,928
Mkt Cap
$2.46BVolume
20.25M52W High
$7.5052W Low
$1.54PE Ratio
-10.95NUVB Fundamentals
Price
$7.01Prev Close
$7.15Open
$7.2050D MA
$4.19Beta
1.50Avg. Volume
8.3MEPS (Annual)
-$2.11P/B
7.37Rev/Employee
$35,786.36Insider Selling: Nuvation Bio (NYSE:NUVB) Insider Sells 15,000 Shares of Stock
Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) insider Dongfang Liu sold 15,000 shares of Nuvation Bio stock in a transaction dated Monday, November 17th. The stock was sold at an average price of...
MarketBeat·5h ago
Nuvation Bio Target of Unusually High Options Trading (NYSE:NUVB)
Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) was the target of some unusual options trading activity on Wednesday. Investors bought 11,651 call options on the stock. This represents an increase of...
MarketBeat·11h ago
Los Angeles Capital Management LLC Buys Shares of 106,020 Nuvation Bio Inc. $NUVB
Los Angeles Capital Management LLC bought a new position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·2d ago
Nuvation Bio (NYSE:NUVB) Trading Up 9.6% - Should You Buy?
Nuvation Bio (NYSE:NUVB) Shares Up 9.6% - What's Next...
MarketBeat·5d ago
Nuvation Bio Inc. (NYSE:NUVB) Given Consensus Rating of "Moderate Buy" by Brokerages
Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) has been given an average rating of "Moderate Buy" by the nine analysts that are presently covering the company, Marketbeat.com reports. One equities...
MarketBeat·11d ago
Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Tops Revenue Estimates
Nuvation Bio (NUVB) delivered earnings and revenue surprises of +5.88% and +95.53%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported financial results for the third quarter ended...
Business Wire·17d ago
Nuvation Bio to Participate in Upcoming Investor Conferences
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief...
Business Wire·21d ago
MiMedx (MDXG) Tops Q3 Earnings and Revenue Estimates
MiMedx (MDXG) delivered earnings and revenue surprises of +114.29% and +19.99%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·22d ago